Eisai Co (TSE:4523) EV-to-Revenue

: 2.10 (As of Today)

View and export this data going back to 1961. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Eisai Co's enterprise value is 円1,573,510 Mil. Eisai Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円749,460 Mil. Therefore, Eisai Co's EV-to-Revenue for today is 2.10.

The historical rank and industry rank for Eisai Co's EV-to-Revenue or its related term are showing as below:

TSE:4523' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.43 Med: 0.87 Max: 4.44
Current: 2.1

During the past 13 years, the highest EV-to-Revenue of Eisai Co was 4.44. The lowest was 0.43. And the median was 0.87.

TSE:4523's EV-to-Revenue is ranked better than
57.17% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 2.33 vs TSE:4523: 2.10

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-19), Eisai Co's stock price is 円5901.00. Eisai Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円2,613.29. Therefore, Eisai Co's PS Ratio for today is 2.26.

Eisai Co EV-to-Revenue Historical Data

The historical data trend for Eisai Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

2.56

3.06

3.08

1.90

2.73

Eisai Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue																3.26	2.73	3.54	2.97	2.57

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eisai Co EV-to-Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Eisai Co's EV-to-Revenue falls into.

Eisai Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Eisai Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1573510.112	/	749460
	=	2.10

Eisai Co's current Enterprise Value is 円1,573,510 Mil.
Eisai Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円749,460 Mil.

Eisai Co (TSE:4523) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Eisai Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	5901.00	/	2613.294
	=	2.26

Eisai Co's share price for today is 円5901.00.
Eisai Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,613.29.

Eisai Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Eisai Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co (TSE:4523) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

ESAIY:USA ESALF:USA EII:Germany

Address

4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088

Website

http://www.eisai.co.jp

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines